Browning M, Banks R, Tribe C, Bacon P, Hollingworth P, Kingswood C, Poulding J, Harrison P, Mackenzie J C
Proc Eur Dial Transplant Assoc. 1983;20:595-602.
In a study of 124 patients with systemic amyloidosis, renal involvement was the major presenting feature in 68 per cent of patients with AA and 42 per cent with AL disease. Renal failure contributed to the deaths of 72 per cent and 33 per cent of patients respectively. In 23 renal biopsies from patients with AA disease, quantitative glomerular amyloid infiltration correlated with urinary protein excretion and with serum creatinine. Seven of these patients had repeat biopsies; change in glomerular amyloid correlated with changes in both renal function and proteinuria. Four patients with end-stage renal amyloidosis have been successfully managed on CAPD for 37 patient months.
在一项针对124例系统性淀粉样变性患者的研究中,肾脏受累是68%的AA型患者和42%的AL型疾病患者的主要表现特征。肾衰竭分别导致72%和33%的患者死亡。在23例AA型疾病患者的肾活检中,肾小球淀粉样蛋白定量浸润与尿蛋白排泄及血清肌酐相关。其中7例患者进行了重复活检;肾小球淀粉样蛋白的变化与肾功能和蛋白尿的变化相关。4例终末期肾淀粉样变性患者已成功接受持续性非卧床腹膜透析治疗37个患者月。